All patients | Patients with only-COPD admissions¶ versus no admissions+ | Patients with nonrespiratory admissions§ versus no admissions+ | ||||
Coefficientƒ (95% CI) | p-value | Coefficientƒ (95% CI) | p-value | Coefficientƒ (95% CI) | p-value | |
Constant## | −7.3 (−15.8–1.2) | 0.088 | −7.7 (−15.8–0.6) | 0.068 | −8.5 (−16.7– −0.3) | 0.043 |
Number of hospital admissions per year during follow-up | ||||||
0 | Reference | Reference | Reference | |||
>0 and ≤1 | −7.4 (−19.1–4.3) | 0.211 | −13.8 (−28.2–2.1) | 0.092 | −1.5 (−18.7–15.7) | 0.865 |
>1 | −26.1 (−38.6– −13.1) | <0.001 | −28.0 (−45.1– −10.7) | 0.002 | −27.3 (−48.9– −5.6) | 0.014 |
Significant dyspnoea¶¶ at baseline | −17.2 (−27.8– −6.6) | 0.002 | −16.9 (−28.3– −5.4) | 0.004 | −15.3 (−26.4– −4.1) | 0.008 |
Age at baseline years | −0.6 (−1.3–0.01) | 0.057 | −0.6 (−1.2–0.1) | 0.089 | −0.6 (−1.3–0.1) | 0.098 |
Female sex | −11.1 (−30.2–7.9) | 0.249 | −8.6 (−29.1–11.9) | 0.407 | −4.3 (−24.9–16.3) | 0.679 |
Baseline body mass index kg·m−2 | −0.3 (−1.5–0.9) | 0.664 | −0.2 (−1.4–1.1) | 0.782 | −0.6 (−1.8–0.7) | 0.389 |
Baseline RV/TLC % | −0.5 (−1.0–0.04) | 0.069 | −0.5 (−1.2–0.1) | 0.087 | −0.4 (−0.9–0.2) | 0.223 |
Baseline PaO2 mmHg | 0.1 (−0.2–0.4) | 0.692 | 0.1 (−0.3–0.4) | 0.726 | 0.1 (−0.2–0.5) | 0.398 |
Baseline 6MWD m | −0.2 (−0.3– −0.1) | <0.001 | −0.2 (−0.3– −0.1) | <0.001 | −0.2 (−0.3– −0.1) | <0.001 |
Adjusted R2 | 0.223 | 0.229 | 0.193 |
RV: residual volume; TLC: total lung capacity; PaO2: arterial oxygen tension. #: linear regression model. ¶: n=77. +: n=189. §: n=43. ƒ: expressed as change in metres of 6MWD per: 1) unit of the continuous covariate, or 2) a change with respect to the reference category in categorical covariates. ##: adjusted mean value based on the linear regression equation corresponding to the mean change in 6MWD in a subject with no COPD hospitalisations per year and modified Medical Research Council score <2, who was male and of mean age, body mass index, RV/TLC, PaO2 and baseline 6MWD; negative values represent decline. ¶¶: modified Medical Research Council score ≥2.